HBIO: Harvard Bioscience Inc. Long-Term Debt Volume

Graphic logo of Harvard Bioscience Inc. (HBIO)

Harvard Bioscience (HBIO) operations are constrained by US-China trade barriers and logistical disruptions in Asia. Stable revenue is driven by customer lock-in to specialized software and maintenance services. The share price retrospective demonstrates the 0.04 indicator. Current growth is supported by the upgrading of automated lines, enabling the company to more rapidly process the backlog of orders for precision equipment.

HBIO Harvard Bioscience, Inc.: Company Long-Term Debts in the range 07/04/2022 - 10/28/2026

Analytical breakdowns for Harvard Bioscience

- price and consensus price forecast:
Share Price harvardbioscience.com|HBIO - Analyst Consensus Forecast
- market capitalization data:
Market Capitalization Harvard Bioscience|HBIO - Enterprise Value
- book capitalization data:
Accounting Value per Share Harvard Bioscience|HBIO - Book Capitalization|Market Capitalization to Book Value Ratio harvardbioscience.com|HBIO - Aggregate Company Assets
- debt and liquidity data:
Debt to Equity Harvard Bioscience|HBIO - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital Harvard Bioscience Inc.|HBIO - Company Aggregate Debts|Debts to Net Assets Harvard Bioscience|HBIO - Company Long-Term Debt|Company Short-Term Indebtedness Harvard Bioscience
General company analysis:harvardbioscience.com (HBIO)
Mass-produced product of harvardbioscience.com

This metric reflects the total volume of liabilities with maturities exceeding twelve months, allowing for an assessment of long-term financial stability and leverage levels relative to industry peers. By analyzing the long-term debt statistics of Harvard Bioscience (HBIO), an investor can confirm the current priority of Harvard Bioscience (HBIO) to optimize margins and integrate assets during a temporary hiatus from new merger and acquisition deals.

Competitor analysis

Company Long-Term Indebtedness intuitive.com ISRG|Company Long-Term Debts DHR (Danaher)|BDX - Long-Term Debt Volume|STE (STERIS Corporation) - Company Long-Term Debts|West Pharma Corp (WST) - Company Long-Term Liabilities|BAX (Baxter International) - Company Long-Term Debts|Company Long-Term Debts MASI|Company Long-Term Debt Stevanato Group (STVN)|Company Long-Term Debt Teleflex Inc. TFX|Company Long-Term Liabilities Merit Medical Systems Inc|Company Long-Term Loans and Borrowings Nobel Biocare NVST|Company Long-Term Debts ICUI (ICU Medical, Inc.)|XRAY: Long-Term Debt Volume|Company Long-Term Debt LeMaitre Vascular|ATRC (AtriCure Inc) - Company Long-Term Indebtedness|STAA: Company Long-Term Debt|Long-Term Debt Volume niagenbioscience.com (NAGE)|Company Long-Term Liabilities ZimVie Inc.|Amount of Long-Term Liabilities ANGO (angiodynamics.com)|Company Long-Term Debt Cerus|TKNO - Company Long-Term Loans and Borrowings|Monogram Technologies Inc - Company Long-Term Liabilities|STSS: Company Long-Term Debts|INFU (infusystem.com) - Company Long-Term Debt|utahmed.com (UTMD) - Company Long-Term Liabilities|Company Long-Term Debts KRMD (KORU Medical Systems, Inc.)|Long-Term Debt NYXH|Company Long-Term Debt Microbot Medical Inc MBOT|Company Long-Term Indebtedness Pro-Dex Inc. PDEX|Company Long-Term Liabilities Zentek Ltd. (ZTEK)|elutia.com - Amount of Long-Term Liabilities|Company Long-Term Debt MLSS (Milestone Scientific Inc.)|NXGL - Long-Term Debt Volume|Company Long-Term Debts retractable.com RVP|Femasys Corporation (FEMY) - Company Long-Term Loans and Borrowings|MHUA (Meihua Medical Technologies) - Company Long-Term Debts|Company Long-Term Debts POAI|Callan JMB Inc (CJMB) - Company Long-Term Debt|Company Long-Term Loans and Borrowings Atrion Corp. ATRI|Company Long-Term Liabilities NeuroMetrix Corp NURO